Search Results for "action"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for action. Results 451 to 460 of 1159 total matches.

Ibuprofen vs. Acetaminophen in Children

   
The Medical Letter on Drugs and Therapeutics • Dec 15, 1989  (Issue 807)
. MECHANISM OF ACTION — Like aspirin and other NSAIDs, ibuprofen decreases pain, fever and inflammation ...
Since the implication of aspirin in Reye's syndrome, acetaminophen (Tylenol; and others) has become the standard drug for symptomatic treatment of fever and pain in children. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) available for many years in tables (Mortin; Advil; and others), has now become available in a suspension. The suspension will be sold by presecription for treatment of fever or arthritis in children.
Med Lett Drugs Ther. 1989 Dec 15;31(807):109-10 |  Show IntroductionHide Introduction

Botulinum Toxin for Ocular Muscle Disorders

   
The Medical Letter on Drugs and Therapeutics • Nov 02, 1990  (Issue 830)
and blepharospasm in patients more than 12 years old. MECHANISM OF ACTION — Type A toxin produced by Clostridium ...
Botulinum toxin Type A (Oculinum - Allergan), used investigationally for many years to treat ocular muscle disorders (Medical Letter, 29:101, 1987), has now been approved by the US Food and Drug Administration for intramuscular treatment of strabismus and blepharospasm in patients more than 12 years old.
Med Lett Drugs Ther. 1990 Nov 2;32(830):100-2 |  Show IntroductionHide Introduction

Capsaicin - A Topical Analgesic

   
The Medical Letter on Drugs and Therapeutics • Jun 26, 1992  (Issue 873)
% capsaicin; the drug was previously available in a 0.025% concentration as Zostrix. MECHANISM OF ACTION ...
Capsaicin, a vanillyl alkaloid found in hot peppers and related plants, is now available without a prescription as Zostrix-HP (GenDerm) for topical relief of pain due to diabetic neuropathy, herpes zoster, or arthritis. The new formulation contains 0.075% capsaicin; the drug was previously available in a 0.025% concentration as Zostrix.
Med Lett Drugs Ther. 1992 Jun 26;34(873):62-3 |  Show IntroductionHide Introduction

Flecainide for Supraventricular Tachyarrhythmias

   
The Medical Letter on Drugs and Therapeutics • Jul 24, 1992  (Issue 875)
atrial action potential duration and refractoriness (Z Wang et al, Circulation, 82:274, 1990). The drug ...
Flecainide (Tambocor -3M Pharmaceuticals), first introduced in 1985 for treatment of ventricular arrhythmias, was recently approved by the US Food and Drug Administration for oral use to prevent supraventricular arrhythmias. The indications for using flecainide to treat ventricular arrhythmias were limited after a controlled trial found that post-myocardial infarction patients with asymptomatic ventricular arrhythmias who took the drug had twice as high a mortality rate as patients who took placebo (DS Echt et al, N Engl Med, 324:781, 1991).
Med Lett Drugs Ther. 1992 Jul 24;34(875):71-2 |  Show IntroductionHide Introduction

Meters for Glucose Monitoring

   
The Medical Letter on Drugs and Therapeutics • Dec 25, 1992  (Issue 886)
it automatically without requiring action on the part of the user; with the ExacTech systems, the user must start ...
Most patients with diabetes mellitus now test their own blood glucose. In recent years, meters commercially available for self-testing have become smaller and easier to use.
Med Lett Drugs Ther. 1992 Dec 25;34(886):115-6 |  Show IntroductionHide Introduction

Rifabutin

   
The Medical Letter on Drugs and Therapeutics • Apr 30, 1993  (Issue 895)
of several drugs (Medical Letter, 33:95, 1991). PHARMACOLOGY — The mechanism of action of rifabutin against ...
Rifabutin (formerly ansamycin; Mycobutin - Adria), a rifamycin antibiotic similar to rifampin (Rifadin, Rimactane) was recently approved by the US Food and Drug Administration for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
Med Lett Drugs Ther. 1993 Apr 30;35(895):36-8 |  Show IntroductionHide Introduction

Captopril for Diabetic Nephropathy

   
The Medical Letter on Drugs and Therapeutics • May 27, 1994  (Issue 923)
in the United States. MECHANISM OF ACTION — In studies of diabetic animals, blocking formation of angiotensin ...
Captopril (Capoten - Bristol-Myers Squibb), an angiotensin-converting enzyme (ACE) inhibitor previously available for treatment of hypertension, has now been approved by the US Food and Drug Administration (FDA) for treatment of diabetic nephropathy in patients with insulin-dependent diabetes mellitus (IDDM). Diabetic nephropathy is the most common cause of end-stage renal disease in the United States.
Med Lett Drugs Ther. 1994 May 27;36(923):46-7 |  Show IntroductionHide Introduction

Calcipotriene for Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 1994  (Issue 928)
common form of the disease. PHARMACOLOGY — The mechanism of action of calcipotriene is unclear. Like ...
Calcipotriene ointment 0.005% (calcipotriol; Dovonex - Westwood Squibb), a synthetic vitamin D 3 analog previously available in Europe and Canada, has now been approved by the US Food and Drug Administration (FDA) for treatment of moderate plaque psoriasis, the most common form of the disease.
Med Lett Drugs Ther. 1994 Aug 5;36(928):70-1 |  Show IntroductionHide Introduction

Doxepin Cream for Pruritus

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 1994  (Issue 934)
dermatoses. Oral doxepin is used as a tricyclic antidepressant (Sinequan, and others). MECHANISM OF ACTION ...
The US Food and Drug Administration has approved the marketing of 5% doxepin hydrochloride cream (Zonalon - GenDerm) for treatment of pruritus due to eczematous dermatoses. Oral doxepin is used as a tricyclic antidepressant (Sinequan, and others).
Med Lett Drugs Ther. 1994 Oct 28;36(934):99-100 |  Show IntroductionHide Introduction

Acarbose for Diabetes Mellitus

   
The Medical Letter on Drugs and Therapeutics • Feb 02, 1996  (Issue 967)
Administration (FDA) for treatment of non-insulin-dependent diabetes mellitus (NIDDM). MECHANISM OF ACTION ...
Acarbose (Precose -Bayer), an oral alpha-glucosidase inhibitor that has been available in Europe for several years, was recently approved by the US Food and Drug Administration (FDA) for treatment of non-insulin-dependent diabetes mellitus (NIDDM).
Med Lett Drugs Ther. 1996 Feb 2;38(967):9-10 |  Show IntroductionHide Introduction